Healthcare Analysts, along with argenx (ARGX) SE CEO Tim Van Hauwermeiren and Dr. Chafic Karam discuss Vyvgart on an Analyst/Industry conference call to be held on April 8 at 1 pm.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx SE Unveils Promising VYVGART Data at AAN 2025
- Argenx SE Files 2024 Annual Report Highlighting VYVGART Expansion
- Argenx’s Vyvgart: Driving Growth and Strategic Expansion with Strong Buy Rating
- Argenx upgraded to Outperform from Market Perform at Bernstein
- Argenx Se: Buy Rating Backed by Vyvgart’s Robust Launch and Promising Pipeline
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue